Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

Similar articles for PubMed (Select 24246700)

1.

Somatic characterization of pediatric acute myeloid leukemia using next-generation sequencing.

Schuback HL, Arceci RJ, Meshinchi S.

Semin Hematol. 2013 Oct;50(4):325-32. doi: 10.1053/j.seminhematol.2013.09.003. Review.

PMID:
24246700
2.

Pediatric acute myeloid leukemia: biology and therapeutic implications of genomic variants.

Tarlock K, Meshinchi S.

Pediatr Clin North Am. 2015 Feb;62(1):75-93. doi: 10.1016/j.pcl.2014.09.007. Epub 2014 Oct 29. Review.

PMID:
25435113
3.

Genomics of AML: clinical applications of next-generation sequencing.

Welch JS, Link DC.

Hematology Am Soc Hematol Educ Program. 2011;2011:30-5. doi: 10.1182/asheducation-2011.1.30. Review.

4.

Perspective on how to approach molecular diagnostics in acute myeloid leukemia and myelodysplastic syndromes in the era of next-generation sequencing.

Kohlmann A, Bacher U, Schnittger S, Haferlach T.

Leuk Lymphoma. 2014 Aug;55(8):1725-34. doi: 10.3109/10428194.2013.856427. Epub 2014 Feb 14. Review.

PMID:
24144312
5.

Integrating genomics into prognostic models for AML.

Sanchez M, Levine RL, Rampal R.

Semin Hematol. 2014 Oct;51(4):298-305. doi: 10.1053/j.seminhematol.2014.08.002. Epub 2014 Aug 12.

PMID:
25311742
6.

Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia.

Radtke I, Mullighan CG, Ishii M, Su X, Cheng J, Ma J, Ganti R, Cai Z, Goorha S, Pounds SB, Cao X, Obert C, Armstrong J, Zhang J, Song G, Ribeiro RC, Rubnitz JE, Raimondi SC, Shurtleff SA, Downing JR.

Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12944-9. doi: 10.1073/pnas.0903142106. Epub 2009 Jul 27.

7.

Genomic tools in acute myeloid leukemia: From the bench to the bedside.

White BS, DiPersio JF.

Cancer. 2014 Apr 15;120(8):1134-44. doi: 10.1002/cncr.28552. Epub 2014 Jan 28. Review.

8.

Identification of recurring tumor-specific somatic mutations in acute myeloid leukemia by transcriptome sequencing.

Greif PA, Eck SH, Konstandin NP, Benet-Pag├Ęs A, Ksienzyk B, Dufour A, Vetter AT, Popp HD, Lorenz-Depiereux B, Meitinger T, Bohlander SK, Strom TM.

Leukemia. 2011 May;25(5):821-7. doi: 10.1038/leu.2011.19. Epub 2011 Feb 22.

PMID:
21339757
9.

[Cancer genome analysis through next-generation sequencing].

Aburatani H.

Gan To Kagaku Ryoho. 2011 Jan;38(1):1-6. Review. Japanese.

PMID:
21368453
10.

Mutational landscape of AML with normal cytogenetics: biological and clinical implications.

Martelli MP, Sportoletti P, Tiacci E, Martelli MF, Falini B.

Blood Rev. 2013 Jan;27(1):13-22. doi: 10.1016/j.blre.2012.11.001. Epub 2012 Dec 20. Review.

PMID:
23261068
11.

Genomic analysis of acute myeloid leukemia: potential for new prognostic indicators.

Eklund EA.

Curr Opin Hematol. 2010 Mar;17(2):75-8. doi: 10.1097/MOH.0b013e3283366c43. Review.

12.

Genomics of acute myeloid leukemia: the next generation.

Riva L, Luzi L, Pelicci PG.

Front Oncol. 2012 May 1;2:40. doi: 10.3389/fonc.2012.00040. eCollection 2012.

13.

Molecular genetics of AML.

Link DC.

Best Pract Res Clin Haematol. 2012 Dec;25(4):409-14. doi: 10.1016/j.beha.2012.10.002. Epub 2012 Oct 23. Review.

14.

The evolving molecular genetic landscape in acute myeloid leukaemia.

Sanders MA, Valk PJ.

Curr Opin Hematol. 2013 Mar;20(2):79-85. doi: 10.1097/MOH.0b013e32835d821c. Review.

PMID:
23380602
15.

Detection of copy number alterations in acute myeloid leukemia and myelodysplastic syndromes.

Jacoby MA, Walter MJ.

Expert Rev Mol Diagn. 2012 Apr;12(3):253-64. doi: 10.1586/erm.12.18. Review.

PMID:
22468816
16.

Therapy of acute myeloid leukemia: towards a patient-oriented, risk-adapted approach.

Mandelli F, Petti MC, Lo Coco F.

Haematologica. 1998 Nov;83(11):1015-23. Review.

17.

AML genomics for the clinician.

Graubert T, Stone R.

Semin Hematol. 2014 Oct;51(4):322-9. doi: 10.1053/j.seminhematol.2014.08.006. Epub 2014 Aug 9.

PMID:
25311744
18.

Genomics of acute myeloid leukemia.

Graubert TA, Mardis ER.

Cancer J. 2011 Nov-Dec;17(6):487-91. doi: 10.1097/PPO.0b013e31823c5652. Review.

19.

Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: a report from the Children's Oncology Group.

Ho PA, Kutny MA, Alonzo TA, Gerbing RB, Joaquin J, Raimondi SC, Gamis AS, Meshinchi S.

Pediatr Blood Cancer. 2011 Aug;57(2):204-9. doi: 10.1002/pbc.23179. Epub 2011 Apr 18.

20.

How do novel molecular genetic markers influence treatment decisions in acute myeloid leukemia?

Patel JP, Levine RL.

Hematology Am Soc Hematol Educ Program. 2012;2012:28-34. doi: 10.1182/asheducation-2012.1.28. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk